Review of the National Partnership Agreement on Essential Vaccines

The National Partnership Agreement on Essential Vaccines (NPEV) provides funding for the purchase of essential vaccines covered by the National Immunisation Programme (NIP), by either the Commonwealth or States and Territories.

Page last updated: 10 June 2015

The Review was required to consider the extent to which the objectives, outcomes and/or outputs of the Review of the National Partnership Agreement on Essential Vaccines (NPEV) have been achieved and whether they have been delivered in an effective and efficient manner. The review was also invited to consider whether the policy or programme remains appropriate and any lessons learned to ensure that performance can be improved in other or possible future agreements.

The NPEV provides funding for the purchase of essential vaccines covered by the National Immunisation Programme (NIP), by either the Commonwealth or States and Territories. It also provides reward payments for achievement against performance benchmarks to improve the cost-effectiveness and performance of their service delivery. The NPEV does not provide funding for delivery of vaccination programs within States and Territories, such as school based programs. Funds for these purposes have been incorporated in National Health Reform Agreement.

The NPEV sets out two objectives:

  • improved health and well-being of Australians through the cost-effective delivery of immunisation programs under the National Immunisation Programme; and
  • maintaining and, where possible, improving immunisation coverage rates through immunisation initiatives to reduce the incidence of vaccine preventable diseases in the Australian population.

It also refers to the following outcomes:

  • minimise the incidence of major vaccine preventable diseases in Australia;
  • maintain and where possible increase immunisation coverage rates for vulnerable groups and, in particular, minimise disparities between Indigenous and non-Indigenous Australians;
  • all eligible Australians are able to access high quality and free essential vaccines through the National Immunisation Programme in a timely manner; and
  • increase community understanding and support for the public health benefits of immunisation.

The NPEV has been effective in providing for the funding and delivery of a national, coordinated and integrated approach to maintaining and improving effective immunisation in Australia. Governments have fulfilled their commitments to one another and all States and Territories have met the performance benchmarks for incentive payments.

In this section